News from biospecifics technologies corp A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NYSE:BLL)

Oct 21, 2014, 08:00 ET

BioSpecifics Technologies Corp. Announces FDA Approval of sBLA for XIAFLEX® for the Concurrent Treatment of Two Dupuytren's Contracture Cords

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed...

Oct 16, 2014, 08:30 ET

BioSpecifics Technologies Corp. Announces Presentation of Encouraging Preclinical Data for CCH from Collaborative Uterine Fibroid Study with Duke Medicine

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Oct 08, 2014, 16:05 ET

BioSpecifics Technologies Corp. Announces Sudden Passing of Director Max Link, Ph.D.

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), today announced with great sadness that Max Link, Ph.D., a member of its Board of Directors,...

Sep 19, 2014, 08:30 ET

BioSpecifics Technologies Corp. to Present at the 21st Annual BioCentury NewsMakers in the Biotech Industry Conference

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Sep 18, 2014, 16:17 ET

BioSpecifics Technologies Corp. Announces New MULTICORD and Retreatment Data for XIAFLEX® for Dupuytren's Contracture Presented at American Society for Surgery of the Hand Annual Meeting

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Sep 02, 2014, 08:00 ET

BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Aug 21, 2014, 17:36 ET

BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Aug 11, 2014, 16:01 ET

BioSpecifics Technologies Corp. Reports Second Quarter 2014 Financial Results

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Aug 08, 2014, 08:30 ET

BioSpecifics Technologies Corp. Announces Initiation of Phase 2 Clinical Study of CCH for Treatment of Lipoma

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Aug 05, 2014, 08:30 ET

BioSpecifics Technologies Corp. Announces Appointment of Max Link, Ph.D. to Board of Directors

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced...

Aug 04, 2014, 08:30 ET

BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2014 Financial Results on Monday, August 11, 2014

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Jun 27, 2014, 08:30 ET

BioSpecifics Technologies Corp. to Be Added to Russell 3000® Index

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Jun 25, 2014, 16:01 ET

BioSpecifics Technologies Corp. Announces Filing by Sobi for EU Approval of XIAPEX for Peyronies Disease

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

May 19, 2014, 17:31 ET

BioSpecifics Announces New Analyses of XIAFLEX for Peyronie's Disease Presented at American Urological Association

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed...

May 12, 2014, 08:00 ET

BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

May 08, 2014, 08:00 ET

BioSpecifics Technologies Corp. Reports First Quarter 2014 Financial Results

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

May 01, 2014, 08:30 ET

BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2014 Financial Results on Thursday, May 8, 2014

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products...

Apr 02, 2014, 08:00 ET

BioSpecifics Technologies Corp. to Present at the 13th Annual Needham Healthcare Conference

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Mar 06, 2014, 08:00 ET

BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2013 Financial Results

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Feb 27, 2014, 08:30 ET

BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2013 Financial Results on Thursday, March 6, 2014

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...